BeiGene, Ltd. - Oct 31, 2024 Form SCHEDULE 13D/A Schedule Report for Leap Therapeutics, Inc. (LPTX)

Filing Manager: BeiGene, Ltd.
Reporting Manager: BeiGene, Ltd.
Security: Leap Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: LPTX
Disclosed Ownership: 1.22M shares
Ownership: 0%
Form type: SCHEDULE 13D/A
Date filed: 10/31/2024, 05:40 PM
Date of event: Oct 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BeiGene, Ltd.	0%	1.22M	1.22M	0	BeiGene, Ltd.	Chan Lee Senior Vice President, General Counsel	0001651308